Georgia Tech and Emory researchers found that delivering vaccine and GLP-1 mRNA nanoparticles through different regions of the gastrointestinal tract can redirect therapies to key organs while reducing side effects.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.